Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,705 | 499 | 79.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,925 | 1 | 19.9% |
| Education | $33.40 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,528 | 99 | $0 (2024) |
| Corium, LLC | $588.24 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $529.43 | 29 | $0 (2024) |
| Novo Nordisk Inc | $459.40 | 36 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $386.01 | 22 | $0 (2024) |
| PFIZER INC. | $375.68 | 22 | $0 (2024) |
| Neos Therapeutics, LP | $341.02 | 21 | $0 (2024) |
| Lilly USA, LLC | $310.94 | 21 | $0 (2024) |
| Allergan, Inc. | $280.03 | 21 | $0 (2020) |
| Amarin Pharma Inc. | $276.57 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,129 | 67 | ABBVIE INC. ($325.32) |
| 2023 | $1,507 | 82 | AbbVie Inc. ($525.98) |
| 2022 | $3,259 | 88 | ABBVIE INC. ($2,310) |
| 2021 | $903.49 | 57 | AbbVie Inc. ($367.17) |
| 2020 | $686.02 | 49 | Allergan, Inc. ($176.67) |
| 2019 | $720.96 | 43 | AstraZeneca Pharmaceuticals LP ($152.82) |
| 2018 | $631.88 | 51 | Synergy Pharmaceuticals Inc ($121.66) |
| 2017 | $825.79 | 68 | Arbor Pharmaceuticals, Inc. ($117.53) |
All Payment Transactions
505 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Neos Therapeutics, LP | Cotempla XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $7.24 | General |
| Category: ADHD | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: VACCINE | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $14.57 | General |
| Category: ADHD | ||||||
| 09/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Oncology | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $16.46 | General |
| Category: ADHD | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: VACCINE | ||||||
| 08/28/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), VAXELIS | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Vaccines | ||||||
| 08/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: VACCINES | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/22/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 394 | 592 | $130,756 | $40,786 |
| 2022 | 10 | 456 | 646 | $138,207 | $44,259 |
| 2021 | 10 | 403 | 515 | $100,797 | $35,077 |
| 2020 | 10 | 420 | 529 | $86,112 | $29,029 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 264 | $71,016 | $18,484 | 26.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 93 | $21,948 | $8,491 | 38.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 60 | $9,900 | $3,640 | 36.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 41 | $5,617 | $2,942 | 52.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $8,262 | $2,395 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 28 | $5,376 | $1,740 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $2,115 | $1,301 | 61.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 19 | 21 | $3,486 | $1,289 | 37.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 16 | 22 | $3,036 | $504.59 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 263 | $70,747 | $18,915 | 26.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 82 | $19,352 | $6,347 | 32.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 29 | $13,311 | $4,407 | 33.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 62 | 63 | $8,631 | $4,298 | 49.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 53 | $8,745 | $2,896 | 33.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $3,915 | $1,981 | 50.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 66 | 68 | $3,196 | $1,840 | 57.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 22 | 31 | $5,146 | $1,685 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 22 | $4,224 | $1,345 | 31.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $940.00 | $545.01 | 58.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 223 | $51,482 | $17,043 | 33.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 60 | 60 | $8,220 | $3,916 | 47.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 23 | $10,107 | $3,575 | 35.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 35 | $8,380 | $2,805 | 33.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 48 | $7,812 | $2,678 | 34.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,791 | $1,427 | 37.6% |
About Dr. Orton Armstrong, M.D
Dr. Orton Armstrong, M.D is a Internal Medicine healthcare provider based in Parkersburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871550947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Orton Armstrong, M.D has received a total of $9,663 in payments from pharmaceutical and medical device companies, with $1,129 received in 2024. These payments were reported across 505 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($7,705).
As a Medicare-enrolled provider, Armstrong has provided services to 1,673 Medicare beneficiaries, totaling 2,282 services with total Medicare billing of $149,151. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Parkersburg, WV
- Active Since 05/01/2006
- Last Updated 08/18/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871550947
Products in Payments
- UBRELVY (Drug) $2,569
- VRAYLAR (Drug) $616.66
- QULIPTA (Drug) $476.75
- Azstarys (Drug) $464.82
- JORNAY PM (Drug) $355.90
- FARXIGA (Drug) $334.09
- Adzenys XR-ODT (Drug) $294.78
- Vascepa (Drug) $276.57
- NURTEC ODT (Drug) $273.47
- TRULICITY (Drug) $231.23
- Ozempic (Drug) $176.52
- Cologuard Collection Kit (Device) $144.89
- Trintellix (Drug) $139.93
- SOLIQUA 100/33 (Biological) $127.45
- AZSTARYS (Drug) $123.42
- Trulance (Drug) $121.66
- BREZTRI (Drug) $121.29
- BEXSERO (Biological) $116.08
- JARDIANCE (Drug) $107.02
- LINZESS (Drug) $105.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parkersburg
Jennifer Leavitt, D.o, D.O
Internal Medicine — Payments: $9,943
William Tomlinson, Md, MD
Internal Medicine — Payments: $8,023
Bairava Kuppuswamy, M.d, M.D
Internal Medicine — Payments: $6,502
Michael Cheshire, D.o, D.O
Internal Medicine — Payments: $5,388
Abiy Kelil, M.d, M.D
Internal Medicine — Payments: $3,922
Brownhilda Santo, Md, MD
Internal Medicine — Payments: $3,793